Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
19 déc. 2024 08h30 HE
|
Gelteq Limited
NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and...
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug
17 déc. 2024 08h30 HE
|
Gelteq Limited
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label...
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
09 déc. 2024 08h30 HE
|
Gelteq Limited
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white...
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand
02 déc. 2024 08h30 HE
|
Gelteq Limited
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white...
Gelteq Announces 400,000 Units Enter into Production in November 2024
26 nov. 2024 08h30 HE
|
Gelteq Limited
NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label...
Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business
12 nov. 2024 09h00 HE
|
Gelteq Limited
NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white...
Gelteq Limited Closes US$5.2 Million Initial Public Offering
30 oct. 2024 10h00 HE
|
Gelteq Limited
NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...
Gelteq Limited Prices US$5.2 Million Initial Public Offering
28 oct. 2024 21h50 HE
|
Geltec Limited
NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of...